(FTA) Large Cap Value AlphaDEX - Overview
Etf: Value Stocks, Large Cap, Equities, Alpha Generation
Dividends
| Dividend Yield | 2.00% |
| Yield on Cost 5y | 3.07% |
| Yield CAGR 5y | 10.93% |
| Payout Consistency | 97.1% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 12.7% |
| Relative Tail Risk | -2.39% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.04 |
| Alpha | 9.27 |
| Character TTM | |
|---|---|
| Beta | 0.739 |
| Beta Downside | 0.811 |
| Drawdowns 3y | |
|---|---|
| Max DD | 18.74% |
| CAGR/Max DD | 0.65 |
Description: FTA Large Cap Value AlphaDEX January 19, 2026
The First Trust Large Cap Value AlphaDEX® Fund (NASDAQ: FTA) aims to allocate at least 90% of its net assets-including any investment-borrowed capital-to the securities that compose its underlying AlphaDEX-based index, which screens for value-oriented stocks within the NASDAQ US 500 Large-Cap universe.
As of the most recent filing (Q4 2025), the ETF carries an expense ratio of 0.55%, manages roughly $1.2 billion in assets, and reports a 30-day SEC yield near 1.8%. Its top sector weights are Financials (≈22%), Consumer Staples (≈18%) and Health Care (≈15%), reflecting a bias toward defensive, cash-generating businesses.
Key macro drivers that can influence the fund’s performance include the Federal Reserve’s policy stance-higher rates tend to compress equity valuations, especially for growth-heavy peers, thereby favoring value stocks-and the U.S. corporate earnings outlook, which remains sensitive to inflation-adjusted consumer spending trends.
For a deeper, data-driven look at how FTA’s value tilt stacks up against alternative strategies, you might explore ValueRay’s analytical platform for independent performance metrics.
What is the price of FTA shares?
Over the past week, the price has changed by +4.12%, over one month by +6.46%, over three months by +14.88% and over the past year by +22.91%.
Is FTA a buy, sell or hold?
What are the forecasts/targets for the FTA price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 107.7 | 14.6% |
FTA Fundamental Data Overview February 02, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 1.22b USD (1.22b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 1.22b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 1.22b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 8.64% (E(1.22b)/V(1.22b) * Re(8.64%) + (debt-free company))
Discount Rate = 8.64% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)